Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19230571 | System and Methods for Gait Analysis and Longitudinal Health and Aging Assessments Including Musculoskeletal Disorders Using Video-Trained Spatio-temporal Graph Neural Networks | June 2025 | September 2025 | Allow | 3 | 0 | 0 | No | No |
| 18311655 | ULTRASOUND DIAGNOSTIC APPARATUS AND CONTROL METHOD FOR ULTRASOUND DIAGNOSTIC APPARATUS | May 2023 | January 2026 | Allow | 33 | 1 | 0 | No | No |
| 18123535 | ELECTRONIC DEVICE AND METHOD FOR CONTROLLING SAME | March 2023 | February 2026 | Allow | 35 | 1 | 0 | No | No |
| 18184523 | CATALYTIC REACTIVE OXYGEN SPECIES SCAVENGER HYDROGEL | March 2023 | March 2026 | Allow | 36 | 1 | 0 | No | No |
| 18183353 | METHOD FOR DETECTING A FAILURE OF AT LEAST ONE COMPONENT OF A CONTINUOUS ANALYTE MONITORING SYSTEM | March 2023 | February 2026 | Allow | 35 | 1 | 0 | Yes | No |
| 18019950 | COLLECTOR FOR LIQUIDS | February 2023 | July 2025 | Allow | 29 | 0 | 0 | No | No |
| 18019963 | COLLECTOR FOR LIQUIDS | February 2023 | July 2025 | Allow | 29 | 0 | 0 | No | No |
| 17974190 | Glucose Level Deviation Detection | October 2022 | December 2025 | Allow | 37 | 1 | 0 | No | No |
| 17918972 | METHOD OF GENERATING AN INDICATION OF MUSCLE FATIGUE, SENSOR AND SYSTEM THEREFOR | October 2022 | December 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17908852 | MEASURING PHYSIOLOGICAL CHARACTERISTICS | September 2022 | November 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17899800 | WEARABLE DEVICE WITH HEART RATE DETECTION, DYNAMIC HEART RATE DETECTION METHOD AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM | August 2022 | September 2025 | Allow | 36 | 1 | 0 | No | No |
| 17822785 | APPARATUS AND METHOD FOR EVALUATING OBSTRUCTIVE SLEEP APNEA WITH PPG SIGNAL | August 2022 | December 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17800455 | A METHOD AND ASSEMBLY FOR DETERMINING A REPRESENTATION WHICH INDICATES THE ACTIVITY OF A LOCUS COERULEUS SYSTEM OF A USER | August 2022 | July 2025 | Allow | 35 | 1 | 0 | No | No |
| 17886653 | APPARATUS AND METHOD FOR USING A PORTABLE THERMAL DEVICE TO QUANTIFY PAIN PERCEPTION | August 2022 | October 2025 | Allow | 38 | 1 | 0 | No | No |
| 17797547 | DEVICE FOR DETECTING PROSTATE FEATURES | August 2022 | June 2025 | Allow | 34 | 0 | 0 | No | No |
| 17795451 | A NON-INVASIVE CONTINUOUS BLOOD GLUCOSE MONITOR | July 2022 | October 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17840419 | MULTILAYERED DETERMINATION OF HEALTH EVENTS USING RESOURCE-CONSTRAINED PLATFORMS | June 2022 | May 2025 | Allow | 35 | 0 | 0 | No | No |
| 17837063 | COGNITIVE ASSESSMENT SYSTEM BASED ON EYE MOVEMENT | June 2022 | July 2025 | Allow | 37 | 1 | 0 | No | No |
| 17829686 | Infrared Glucose Monitoring Wristband Device | June 2022 | January 2026 | Abandon | 43 | 2 | 0 | No | No |
| 17827286 | METHOD AND DEVICE FOR PROVIDING AUDITORY PROGRAM SIMULATING ON-THE-SPOT EXPERIENCE | May 2022 | October 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17734295 | DYNAMIC MODIFICATION OF CALIBRATION FREQUENCY | May 2022 | August 2025 | Allow | 39 | 1 | 0 | No | No |
| 17548011 | INTERPENETRATING MICROSTRUCTURES FOR NANOCHANNEL-BASED SAMPLING AND/OR CARGO DELIVERY | January 2022 | May 2025 | Allow | 41 | 0 | 1 | No | No |
| 17551918 | Vision Testing System and Method | December 2021 | May 2025 | Allow | 41 | 1 | 0 | No | No |
| 17547824 | Methods For Analyzing Body Composition | December 2021 | June 2025 | Allow | 42 | 1 | 0 | No | No |
| 17538253 | OUTPUT DEVICE FOR OUTPUTTING A MEASURED VALUE PROGRESSION | November 2021 | July 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17536763 | SPECTRO-TEMPORAL MODULATION TEST UNIT | November 2021 | August 2025 | Allow | 44 | 2 | 0 | No | No |
| 17537044 | DETECTING DEVICE AND MEASURING DEVICE | November 2021 | May 2025 | Allow | 41 | 1 | 0 | No | No |
| 17533171 | ORTHOSTATIC HYPOTENSION MONITORING METHOD AND APPARATUS | November 2021 | August 2025 | Allow | 44 | 1 | 1 | No | No |
| 17531828 | Detecting impaired physiological function by speech analysis | November 2021 | February 2025 | Allow | 39 | 1 | 1 | No | No |
| 17527393 | CATHETER DRIVE SYSTEM FOR SUPRA-AORTIC ACCESS | November 2021 | March 2025 | Allow | 40 | 1 | 0 | No | No |
| 17510257 | PRESSURE-SENSING GUIDEWIRE | October 2021 | May 2025 | Allow | 42 | 1 | 1 | No | No |
| 17488919 | EXTERNAL URINE BAGS AND METHODS OF MAKING AND USING THE SAME | September 2021 | March 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17356974 | LOW NOISE MEASUREMENT OF IMPEDANCE OF A PATIENT | June 2021 | June 2025 | Allow | 48 | 2 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner DOAN, HY KHANH works in Art Unit 3791 and has examined 12 patent applications in our dataset. With an allowance rate of 83.3%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 42 months.
Examiner DOAN, HY KHANH's allowance rate of 83.3% places them in the 57% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by DOAN, HY KHANH receive 1.00 office actions before reaching final disposition. This places the examiner in the 9% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by DOAN, HY KHANH is 42 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +18.2% benefit to allowance rate for applications examined by DOAN, HY KHANH. This interview benefit is in the 60% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 16.7% of applications are subsequently allowed. This success rate is in the 14% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.